You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《沪深股市》上证全日升4点 深成创板扬1.4%至2% 成交未见活跃
阿思达克 08-24 15:01
本周关注内银股上半年业绩。内地已启动新冠疫苗紧急使用,考虑扩大使用范围。人行今(24日)开展共1,600亿人民币(下同)逆回购操作。上证高开後靠稳,深成创板显着上升,惟尾市升幅略为收窄。

上证全日升4点或0.2%,收报3,385点;深成升188点或1.4%,收报13,666点;创业板指数升52点或2%,收报2,684点。沪深两市成交未见活跃,分别为3,457亿元及5,514亿元。

银行、保险、券商股偏软。工行(601398.SH)跌0.4%。国寿(601628.SH)、新华保险(601336.SH)分别跌2.4%及2.7%。中信建投(601066.SH)、中信证券(600030.SH)分别跌0.6%及0.4%。

乳业股续升,天润乳业(600419.SH)续涨停。西部牧业(300106.SZ)、光明乳业(600597.SH)分别涨12.7%及8%。

疫苗股受压,康希诺生物(688185.SH)绩後回吐,股价挫11.6%,收报308.39元。君正集团(601216.SH)挫7.9%。

创业板改革并试点注册制首批企业今上市,创业板新股康泰医学(300869.SH)暴升逾10倍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account